Bioheng Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioheng biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioheng Biotech Today - Breaking & Trending Today

CAR-T therapy safe for relapsed or refractory T-cell malignancies, finds study

A Phase I trial revealed chimeric antigen receptor (CAR) T-cell therapy RD13-01 was safe for use and that it could reduce malignant tumours. ....

Jiangtao Ren , Zhejiang University School Of Medicine , Cell Research , Bioheng Biotech , First Affiliated Hospital , Zhejiang University School , Chief Scientific ,